Fien De Boever

775 total citations
17 papers, 491 citations indexed

About

Fien De Boever is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Fien De Boever has authored 17 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 6 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in Fien De Boever's work include Influenza Virus Research Studies (7 papers), Respiratory viral infections research (6 papers) and Pneumonia and Respiratory Infections (4 papers). Fien De Boever is often cited by papers focused on Influenza Virus Research Studies (7 papers), Respiratory viral infections research (6 papers) and Pneumonia and Respiratory Infections (4 papers). Fien De Boever collaborates with scholars based in Belgium, United States and Germany. Fien De Boever's co-authors include Geert Leroux‐Roels, Cathy Maes, Isabel Leroux‐Roels, Frédéric Clément, François Roman, Emmanuel Hanon, Philippe Moris, Marie‐Ange Demoitié, Pascal Mettens and Edouard Ledent and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Frontiers in Immunology.

In The Last Decade

Fien De Boever

14 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fien De Boever Belgium 10 361 185 179 74 74 17 491
Cathy Maes Belgium 10 326 0.9× 128 0.7× 108 0.6× 45 0.6× 71 1.0× 13 441
Taff Jones Canada 11 260 0.7× 152 0.8× 155 0.9× 60 0.8× 19 0.3× 20 396
Timothy D. Carroll United States 10 163 0.5× 157 0.8× 127 0.7× 47 0.6× 75 1.0× 14 342
Mohinder Sidhu United States 13 583 1.6× 83 0.4× 159 0.9× 57 0.8× 36 0.5× 16 654
Jesse Bodle Australia 7 180 0.5× 119 0.6× 86 0.5× 46 0.6× 19 0.3× 10 346
Helen May‐Lin Oh Singapore 9 308 0.9× 74 0.4× 233 1.3× 41 0.6× 64 0.9× 12 408
Anne‐Marte Bakken Kran Norway 15 207 0.6× 82 0.4× 301 1.7× 82 1.1× 24 0.3× 36 518
Xavier Bouhy Canada 13 541 1.5× 103 0.6× 119 0.7× 138 1.9× 29 0.4× 17 591
Mirian Fernández-Alonso Spain 13 297 0.8× 76 0.4× 118 0.7× 60 0.8× 16 0.2× 26 416
Shahjahan Miah United Kingdom 10 266 0.7× 52 0.3× 142 0.8× 83 1.1× 25 0.3× 16 392

Countries citing papers authored by Fien De Boever

Since Specialization
Citations

This map shows the geographic impact of Fien De Boever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fien De Boever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fien De Boever more than expected).

Fields of papers citing papers by Fien De Boever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fien De Boever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fien De Boever. The network helps show where Fien De Boever may publish in the future.

Co-authorship network of co-authors of Fien De Boever

This figure shows the co-authorship network connecting the top 25 collaborators of Fien De Boever. A scholar is included among the top collaborators of Fien De Boever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fien De Boever. Fien De Boever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
D’Onofrio, Valentino, Matthias Verstraete, Fien De Boever, et al.. (2025). A Novel Carbohydrate Fatty-Acid Monosulphate Ester, Squalane-in-Water Adjuvant Is Safe and Enhances Inactivated Influenza Vaccine Immunogenicity in Older Adults. Vaccines. 13(9). 922–922.
2.
D’Onofrio, Valentino, Alfredo Santana, Fien De Boever, et al.. (2025). AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cells. Frontiers in Immunology. 16. 1623405–1623405.
3.
4.
Leroux‐Roels, Isabel, Jacques Bruhwyler, Nicola Groth, et al.. (2024). Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older Adults. Vaccines. 12(12). 1391–1391. 2 indexed citations
5.
Leroux‐Roels, Isabel, et al.. (2024). Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study. The Journal of Infectious Diseases. 231(3). e511–e520. 3 indexed citations
6.
Leroux‐Roels, Isabel, Paul Willems, Yorick Janssens, et al.. (2023). Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial. The Lancet Infectious Diseases. 23(12). 1360–1369. 11 indexed citations
7.
Leroux‐Roels, Isabel, Fien De Boever, Jacques Bruhwyler, et al.. (2022). Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine. Frontiers in Immunology. 13. 852904–852904. 20 indexed citations
8.
9.
Leroux‐Roels, Geert, Cathy Maes, Annelies Aerssens, et al.. (2019). Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4–6 Years After a First Dose: Results From a Phase 2 Trial. Clinical Infectious Diseases. 70(12). 2570–2579. 22 indexed citations
10.
11.
Leroux‐Roels, Geert, Cathy Maes, Julie Willekens, et al.. (2016). A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women. Vaccine. 34(15). 1786–1791. 50 indexed citations
12.
Leroux‐Roels, Geert, Cathy Maes, Fien De Boever, et al.. (2014). Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study. Vaccine. 32(50). 6838–6846. 55 indexed citations
13.
14.
Leroux‐Roels, Geert, Edwige Haelterman, Cathy Maes, et al.. (2011). Randomized Trial of the Immunogenicity and Safety of the Hepatitis B Vaccine Given in an Accelerated Schedule Coadministered with the Human Papillomavirus Type 16/18 AS04-Adjuvanted Cervical Cancer Vaccine. Clinical and Vaccine Immunology. 18(9). 1510–1518. 18 indexed citations
15.
Roman, François, Frédéric Clément, Walthère Dewé, et al.. (2011). Effect on Cellular and Humoral Immune Responses of the AS03 Adjuvant System in an A/H1N1/2009 Influenza Virus Vaccine Administered to Adults during Two Randomized Controlled Trials. Clinical and Vaccine Immunology. 18(5). 835–843. 44 indexed citations
16.
17.
Boever, Fien De, et al.. (2003). [Non-traumatic dislocations of the cervical spine].. PubMed. 39(1). 24–69.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cathy Maes Breakdown of academic impact, for papers by Taff Jones Breakdown of academic impact, for papers by Timothy D. Carroll Breakdown of academic impact, for papers by Mohinder Sidhu Breakdown of academic impact, for papers by Jesse Bodle Breakdown of academic impact, for papers by Helen May‐Lin Oh Breakdown of academic impact, for papers by Anne‐Marte Bakken Kran Breakdown of academic impact, for papers by Xavier Bouhy Breakdown of academic impact, for papers by Mirian Fernández-Alonso Breakdown of academic impact, for papers by Shahjahan Miah
Rankless by CCL
2026